News

FDA Issues Strong Warning on Anemia Drug Risks
Ryan Marotta, Assistant Editor
Ferumoxytol (Feraheme) has been responsible for a number of serious reactions and deaths since its 2009 approval.
Ryan Marotta, Assistant Editor
The FDA today approved a new administration option for ticagrelor (Brilinta).
Michael R. Page, PharmD, RPh
A veritable alphabet soup of hypertension guidelines have been released over the past year. Here is what you need to know.
Meghan Ross, Associate Editor
Changes to immunization schedules, a review of this season’s flu shot, and potential vaccines in the pipeline were broached at the American Pharmacist Association’s Annual Meeting and Exposition session on immunizations.
Meghan Ross, Associate Editor
A former pharmacy technician in Massachusetts has pleaded not guilty to charges of drug trafficking and larceny.
Krystle Vermes
The FDA refused to approve the ultra-long-acting insulin treatments 2 years ago.
The completed endowment included a $37,000 pledge from the National Association of Nuclear Pharmacies.
Registration is now open for first US session of patient care skills development program.

Association News

The completed endowment included a $37,000 pledge from the National Association of Nuclear Pharmacies.
Registration is now open for first US session of patient care skills development program.
More than 350 pharmacy advocates from 44 states met with members of Congress during NACDS RxIMPACT Day on Capitol Hill.
The initiative will establish network to learn and share best practices to provide better quality and more efficient care.
As part of the initiative, PAPCC will run print and digital advertising in beltway media outlets over the course of the Congressional calendar.

Pharmacy Market News

Collaboration with Aduro is focused on discovery and development of next generation cancer immunotherapies targeting the STING signaling pathway.
Expected to strengthen Teva's core CNS franchise, establish Teva's leadership in underserved movement disorders space, provide compelling new treatment options for patients in need, and enhance Teva's long-term revenue and earnings growth.
The collaboration aims to educate adults with diabetes about their increased risk for potentially serious health problems, including pneumococcal pneumonia, influenza, and hepatitis B.

Strategic Alliance Partner News

$AD300x250BB$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$